Name | Hardin Medical Center |
---|---|
Type | Acute Care Hospital |
Location | 935 Wayne Road, Savannah, Tennessee |
Ownership | Government - Local |
Emergency Services | Yes |
Medicare ID (CCN) | 440109 |
NPI Number | 1033259924 |
Organization Name | HARDIN COUNTY GENERAL HOSPITAL |
Address | 935 Wayne Rd, Savannah, TN 38372 |
Hospital Type | General Acute Care Hospital - Rural |
Phone Number | 731-926-8173 |
News Archive
MultiCell Technologies, Inc. has retained Clinical Development & Support Services, Ltd. (CDSS) of Cheshire, England to manage its planned Phase IIb clinical trial in the United Kingdom for MCT-125, the Company's lead drug candidate for treatment of primary multiple sclerosis-related fatigue (PMSF).
Liver cancer affects hundreds of thousands of people annually, and there are few viable therapies for the advanced stages of its most common form-hepatocellular carcinoma.
We need death panels. Well, maybe not death panels, exactly, but unless we start allocating health care resources more prudently - rationing, by its proper name - the exploding cost of Medicare will swamp the federal budget.
Development of drug resistance in the parasite which causes river blindness could lead to breakouts of the disease in communities where it has been brought under control, conclude authors of an article in The Lancet.
Brain samples from humans show that the treatment window for Fragile X syndrome likely remains open well into maturity after childhood, when previous tests with mice indicated it might close, according to a new Drexel University-led study.
› Verified 7 days ago
NPI Number | 1609917202 |
Organization Name | HARDIN COUNTY GENERAL HOSPITAL |
Doing Business As | HARDIN MEDICAL CENTER |
Address | 935 Wayne Rd, Savannah, TN 38372 |
Hospital Type | General Acute Care Hospital |
Phone Number | 731-926-8000 |
News Archive
MultiCell Technologies, Inc. has retained Clinical Development & Support Services, Ltd. (CDSS) of Cheshire, England to manage its planned Phase IIb clinical trial in the United Kingdom for MCT-125, the Company's lead drug candidate for treatment of primary multiple sclerosis-related fatigue (PMSF).
Liver cancer affects hundreds of thousands of people annually, and there are few viable therapies for the advanced stages of its most common form-hepatocellular carcinoma.
We need death panels. Well, maybe not death panels, exactly, but unless we start allocating health care resources more prudently - rationing, by its proper name - the exploding cost of Medicare will swamp the federal budget.
Development of drug resistance in the parasite which causes river blindness could lead to breakouts of the disease in communities where it has been brought under control, conclude authors of an article in The Lancet.
Brain samples from humans show that the treatment window for Fragile X syndrome likely remains open well into maturity after childhood, when previous tests with mice indicated it might close, according to a new Drexel University-led study.
› Verified 7 days ago
NPI Number | 1699754812 |
Organization Name | HARDIN COUNTY GENERAL HOSPITAL |
Doing Business As | HARDIN MEDICAL CENTER |
Address | 935 Wayne Road, Savannah, TN 38372 |
Hospital Type | General Acute Care Hospital |
Phone Number | 731-926-8000 |
News Archive
MultiCell Technologies, Inc. has retained Clinical Development & Support Services, Ltd. (CDSS) of Cheshire, England to manage its planned Phase IIb clinical trial in the United Kingdom for MCT-125, the Company's lead drug candidate for treatment of primary multiple sclerosis-related fatigue (PMSF).
Liver cancer affects hundreds of thousands of people annually, and there are few viable therapies for the advanced stages of its most common form-hepatocellular carcinoma.
We need death panels. Well, maybe not death panels, exactly, but unless we start allocating health care resources more prudently - rationing, by its proper name - the exploding cost of Medicare will swamp the federal budget.
Development of drug resistance in the parasite which causes river blindness could lead to breakouts of the disease in communities where it has been brought under control, conclude authors of an article in The Lancet.
Brain samples from humans show that the treatment window for Fragile X syndrome likely remains open well into maturity after childhood, when previous tests with mice indicated it might close, according to a new Drexel University-led study.
› Verified 7 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
MultiCell Technologies, Inc. has retained Clinical Development & Support Services, Ltd. (CDSS) of Cheshire, England to manage its planned Phase IIb clinical trial in the United Kingdom for MCT-125, the Company's lead drug candidate for treatment of primary multiple sclerosis-related fatigue (PMSF).
Liver cancer affects hundreds of thousands of people annually, and there are few viable therapies for the advanced stages of its most common form-hepatocellular carcinoma.
We need death panels. Well, maybe not death panels, exactly, but unless we start allocating health care resources more prudently - rationing, by its proper name - the exploding cost of Medicare will swamp the federal budget.
Development of drug resistance in the parasite which causes river blindness could lead to breakouts of the disease in communities where it has been brought under control, conclude authors of an article in The Lancet.
Brain samples from humans show that the treatment window for Fragile X syndrome likely remains open well into maturity after childhood, when previous tests with mice indicated it might close, according to a new Drexel University-led study.
› Verified 7 days ago
Hardin Medical Center Acute Care Hospital Location: 935 Wayne Road, Savannah, Tennessee 38372 Phone: (731) 926-8121 |